載入...
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis
Background: Cabozantinib, a multiple kinase inhibitor, was recently approved for patients with previously treated unresectable hepatocellular carcinoma (uHCC). We investigated the real-world safety and efficacy profiles of cabozantinib. Methods: This multicenter retrospective study included 110 pati...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publishing
2022-05-01
|
| 叢編: | Therapeutic Advances in Medical Oncology |
| 在線閱讀: | https://doi.org/10.1177/17588359221097934 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|